Lensar (LNSR) Cash from Financing Activities (2019 - 2026)
Lensar (LNSR) reported Cash from Financing Activities of -$209000.0 for Q1 2026, down 102.16% year-over-year from $9.7 million in Q1 2025, and down 144.09% quarter-over-quarter from $474000.0 in Q4 2025.
Lensar (LNSR) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash from Financing Activities data on file, last reported at -$209000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$209000.0, down 102.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $358000.0 (down 96.38% YoY), and the FY2025 annual result was $10.3 million, up 13051.28% from the prior year.
- Cash from Financing Activities fell to -$209000.0 in Q1 2026 per LNSR's latest filing, from $474000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $9.7 million in Q1 2025 and troughed at -$1.2 million in Q3 2022.
- A 5-year average of $755333.3 and a median of $111000.0 in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities surged 7554.62% in 2025, then tumbled 102.16% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at $196000.0 in 2022, then slipped by 25.51% to $146000.0 in 2023, then climbed by 17.81% to $172000.0 in 2024, then surged by 175.58% to $474000.0 in 2025, then slumped by 144.09% to -$209000.0 in 2026.
- Business Quant data shows LNSR's Cash from Financing Activities at -$209000.0 in Q1 2026, $474000.0 in Q4 2025, and $93000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | -209,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209,000.00 |
| Mar 31, 2026 | -209,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 9.69 Mn |
| Mar 31, 2025 | 9.69 Mn |
| Dec 31, 2024 | 172,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | -205,000.00 |
| Sep 30, 2023 | -205,000.00 |